What’s next? Navigating the insurance process.

Starting a new treatment can be overwhelming. It may seem like there is a lot to learn about insurance. Find out how a Nurse Case Manager (NCM) works behind the scenes to help get you started on treatment.

NCM=Nurse Case Manager

VYVGART for IV infusion is the #1 most prescribed biologic gMG treatment for adults with anti-AChR antibody positive gMG*

VYVGART for IV infusion has been used for more than 2 years.

VYVGART is widely available

>90%

VYVGART for IV infusion is covered for >90% of commercial and Medicare insured patients†

Multiple treatment cycles are possible with the first prescription

>90%

of commercial and Medicare insured patients have coverage allowing for an initial authorization of VYVGART for IV infusion for at least 6 months.† This can allow for multiple infusion cycles with the first prescription

*Based on IQVIA LAAD data from January 2023 to October 2023. Data is based on validated claims of VYVGART for IV infusion and other biologics that have been approved by FDA for the treatment of adults with anti-AChR antibody positive gMG. All claims are associated with patients who received 2 confirmed diagnoses of anti-AChR antibody positive gMG. Patients who were prescribed more than 1 of the biologics in this data set were counted for each biologic prescribed.
†Based on policy reporter data as of January 2024.
AChR=acetylcholine receptor; gMG=generalized myasthenia gravis; LAAD=Longitudinal Access and Adjudication Data; REMS=Risk Evaluation and Mitigation Strategies

Find out how My VYVGART Path helps

Explore the steps to treatment and how a dedicated NCM helps guide you.

LEARN MORE

Have you just been prescribed VYVGART Hytrulo or VYVGART?

The “What’s Next?” patient guide outlines what you can expect as you begin your treatment journey, from navigating insurance to starting your first treatment cycle.

DOWNLOAD THE GUIDE

Resources to help you navigate the insurance process

VYVGART Co-pay program brochure

VYVGART Co-pay program brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.

DOWNLOAD NOW

My VYVGART Path Patient Support Program

My VYVGART Path Patient Support Program

See the different ways a Nurse Case Manager can support you when you enroll in My VYVGART Path.

DOWNLOAD NOW

Doctor discussion guide

Doctor discussion guide

Use this guide to help you engage in productive conversations with your doctor.

DOWNLOAD NOW

My VYVGART Path

Enroll in My VYVGART Path

There are 2 options to enroll once your doctor has prescribed you VYVGART:

Option 1

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Option 2

Download the patient form.

PATIENT ENROLLMENT FORM

Once enrolled in MY VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a symptom tracking journal and other helpful resources.

Cost and access

Your out-of-pocket cost for VYVGART may vary depending on your insurance plan. Many different factors may impact your treatment cost.

Your insurer’s co-payco-pay, co-insuranceco-insurance, deductibledeductible, and out-of-pocket maximumout-of-pocket maximum requirements for medications may affect your out-of-pocket costs.

Where you receive treatment, your site of caresite of care, and whether your provider or specialty pharmacy is in networknetwork may also affect your out-of-pocket costs.

Understanding your insurance

Getting started on treatment and navigating insurance can feel complicated. Expand each term to learn more about the basics of health insurance.

Medicare is a federal insurance program for adults aged 65 years or older. Younger individuals with certain types of disabilities or permanent kidney failure may also qualify.

Medicare may cover treatments for FDA-approved indications. This insurance program has 4 parts (A, B, C, and D), each providing a specific type of coverage.

  • Medicare Part A covers inpatient hospital stays, care in a skilled nursing facility, hospice care, and some home healthcare
  • Medicare Part B helps cover doctors’ and other healthcare providers’ services, outpatient care, home healthcare, durable medical equipment, and many preventive services
  • Medicare Part C (Medicare Advantage) is a Medicare-approved plan from a private company that offers an alternative to Original Medicare for your health and drug coverage. These “bundled” plans include Part A, Part B, and usually Part D
  • Medicare Part D helps cover the cost of prescription drugs
  • Medicare Supplement Insurance (Medigap) is extra insurance you can buy from a private company that helps pay your share of costs in Original Medicare  

Medicaid is a health insurance program that is administered by the government. Medicaid may provide coverage for families with low income, individuals who are pregnant, older adults, and people with disabilities. Each state has different eligibility rules.

Commercial insurance, also called private insurance, is provided and administered by a private insurance company. You may receive this insurance from your employer or purchase it from the Health Insurance Marketplace.

A summary of benefits is a short, plain-language summary about a health plan’s benefits and coverage. You can use it to compare the benefits and cost of different insurance plans.

Most insurance companies need to pre-approve specific healthcare services, prescriptions, or equipment before you can receive it. This process for getting approval is called a prior authorization (pre-authorization).

Each insurance company's timeline for the VYVGART prior authorization process may vary. Medicare does not require prior authorization. Reach out to your Nurse Case Manager if you have questions about the process or need an update.

Footer logos
VYVGART®-Combined-RGB_KO-VERTICAL

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works, study data, cost and coverage, and more.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Questions? Call 1-833-VYVGART
(1-833-898-4278)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

Prescribing Information
VYVGART for IV infusion Prescribing Information VYVGART Hytrulo for subcutaneous injection Prescribing Information

VYVGART is a registered trademark of argenx.
VYVGART Hytrulo is a trademark of argenx.

For U.S. audiences only.

©2024 argenx 

US-VYV-23-00232 V5 07/2024

argenx